Page last updated: 2024-08-24

goralatide and Carcinoma, Epidermoid

goralatide has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cappelaere, P; Carde, P; Chauvergne, J; De Gislain, C; Domenge, C; Dufour-Esquerré, F; Hecquet, B; Krakowski, I; Meeus, L; Rolland, F	1
Bogden, AE; Carde, P; de Paillette, ED; Frindel, E; Moreau, JP; Tubiana, M	1

Trials

1 trial(s) available for goralatide and Carcinoma, Epidermoid

Article	Year
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]. Bulletin du cancer, 1995, Volume: 82, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos	1995

Article

Year

[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].

Bulletin du cancer, 1995, Volume: 82, Issue:9

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos

1995

Other Studies

1 other study(ies) available for goralatide and Carcinoma, Epidermoid

Article	Year
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Annals of the New York Academy of Sciences, 1991, Volume: 628 Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous	1991

Article

Year

Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.

Annals of the New York Academy of Sciences, 1991, Volume: 628

Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous

1991